Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
These allergic reactions are rare but can be life-threatening
Main human AOD-9604 treatment timelines Study METAOD004 Participants 36 Route Oral Treatment length 7 days Dose range 9, 27, or 54 mg/day Main lesson Short safety and tolerability study Study METAOD005 Participants 300 Route Oral Treatment length 12 weeks Dose range 1 to 30 mg/day Main lesson Earlier weight-loss trial with a non-linear dose response Study METAOD006 Participants 502 randomized Route Oral Treatment length 24 weeks Dose range 0.25, 0.5, or 1 mg/day Main lesson Primary weight-loss goal was not met The oral milligram doses in these trials cannot be converted into subcutaneous microgram doses
Potential to Aid with Joint and Cartilage Restoration New research suggests that AOD 9604 can provide joint and cartilage restoration as well
The compatibility classification from our patient protocol guides is moderate and sequential only, which means it is used as a standalone cellular reset cycle, not as part of a multi-peptide stack running simultaneously
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
